T2D
| Title | Status |
|---|---|
| HillaryEffects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: A target trial analysis of a Hospital-based cohort of Thai patients with type 2 diabetes | Submitted |
|
Type 2 Diabetes Mellitus Complications: A Thai real-world clinical cohort |
Submitted |
|
Effects of second-line antihyperglycemic drugs on the risk of CVD |
Drafting MS (internal revision by John & Gareth) |
|
Disease Progression of diabetic complications: ML |
Drafting MS |
|
Short and Long term outcomes between patients who are treated in DM clinic vs non-DM clinic |
Analysis done |
|
Progression of diabetic retinopathy with time-varying model |
Analysis done |
|
Prognostic factor on heart failure in T2D subjects |
Analysis done |
|
Cost-Utility Analysis of Laparoscopic Bariatric Surgery on T2D with obesity subject |
On-going |
|
T2D Real-world medications use (Novo nordisk) |
On-going |
|
T2D GLP1 medication with BMI |
On-going |
|
T2D Fracture and 2ndline medications |
On-going |
|
T2D Fatty Liver |
On-going |
|
T2D Curcumin |
On-going |
CKD
| Title | Status |
|---|---|
|
ESA in anemia: risk and benefit (Hb level, CVD, stroke/thrombosis; SE of PRCA) |
On-going |
|
Does ketosteril slow CKD progression? |
On-going |
|
CKD Mineral and Bone Disorder(MBD): progression |
On-going |
HT
| Title | Status |
|---|---|
|
Hospital-based cohort of Thai patients with hypertension |
Drafting MS |
|
Disease progression of Hypertension and comorbidities |
On-going |
Stroke
| Title | Status |
|---|---|
|
Hospital-based cohort of Thai patients with hypertension |
Drafting MS |
|
Disease progression of Hypertension and comorbidities |
On-going |
AF
| Title | Status |
|---|---|
|
Clinical effectiveness and safety of direct oral anticoagulants and warfarin in patients with nonvalvular atrial fibrillation |
Planning |
|
Risk prediction model of ischemic stroke and thromboembolism in patients with nonvalvular atrial fibrillation: traditional statistical model versus machine learning |
Planning |
|
Counterfactual treatment model |
Planning |
Prostate Cancer
| Title | Status |
|---|---|
|
Clinical effectiveness and cost-utility analysis of treatment for metastatic hormone sensitive prostate cancer: Evidence from real-patients data |
On-going |
|
Using deep learning algorithm for Gleason grading of prostate cancer from biopsy specimens |
On-going |
| The association of prostate-specific antigen (PSA) threshold with prostate cancer changing stage and progression: Real world data | Planning |
Surgery
| Title | Status |
|---|---|
|
External validation and revision of Penn incisional hernia prediction model: A |
Submitted |